PHARMANOVIA CEO, JAMES BURT APPOINTED CHAIR OF MEDICINES FOR EUROPE'S VALUE ADDED MEDICINES (VAM) SECTOR GROUP
Pharmanovia, a global pharmaceutical company that repurposes and expands the lifecycle of novel and established medicines using value added approaches, is pleased to announce the appointment of James Burt as the new Chair of Medicines for Europe’s, Value Added Medicines (VAM) Sector Group. The VAM Sector...